DK3630093T3 - Behandling af sygdomme associeret med en dysregulering af mtor-vejen - Google Patents
Behandling af sygdomme associeret med en dysregulering af mtor-vejenInfo
- Publication number
- DK3630093T3 DK3630093T3 DK18733182.2T DK18733182T DK3630093T3 DK 3630093 T3 DK3630093 T3 DK 3630093T3 DK 18733182 T DK18733182 T DK 18733182T DK 3630093 T3 DK3630093 T3 DK 3630093T3
- Authority
- DK
- Denmark
- Prior art keywords
- dystrulation
- treatment
- diseases associated
- mtor pathway
- mtor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17305620 | 2017-05-30 | ||
| PCT/EP2018/064282 WO2018220068A1 (en) | 2017-05-30 | 2018-05-30 | TREATMENT OF DISEASES ASSOCIATED WITH A DYSREGULATION OF THE mTOR PATHWAY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3630093T3 true DK3630093T3 (da) | 2025-10-20 |
Family
ID=59054052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18733182.2T DK3630093T3 (da) | 2017-05-30 | 2018-05-30 | Behandling af sygdomme associeret med en dysregulering af mtor-vejen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200179335A1 (da) |
| EP (1) | EP3630093B1 (da) |
| JP (1) | JP7395358B2 (da) |
| CA (1) | CA3065417A1 (da) |
| DK (1) | DK3630093T3 (da) |
| ES (1) | ES3053709T3 (da) |
| PL (1) | PL3630093T3 (da) |
| WO (1) | WO2018220068A1 (da) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE795893A (fr) | 1972-02-28 | 1973-06-18 | Unicler | Derives de (methylene dioxy-3,4 phenyl)-1 dimethyl-4,4 pentene-1, leur preparation et leur application en therrapeutique |
| EP1546369A4 (en) * | 2002-08-12 | 2007-01-17 | Univ Michigan | DIAGNOSIS AND TREATMENT OF DISEASES THROUGH DEFECTS IN THE TUBEROUS SKLEROSEPFAD |
| EP2201950B1 (en) | 2008-12-08 | 2016-11-16 | Biocodex | Compounds and methods for treating autism spectrum disorders |
| WO2014115764A1 (ja) | 2013-01-25 | 2014-07-31 | 国立大学法人岡山大学 | 乳酸脱水素酵素阻害剤およびそれを含有する医薬品 |
| GB2531281A (en) * | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
-
2018
- 2018-05-30 EP EP18733182.2A patent/EP3630093B1/en active Active
- 2018-05-30 US US16/617,720 patent/US20200179335A1/en active Pending
- 2018-05-30 JP JP2019565866A patent/JP7395358B2/ja active Active
- 2018-05-30 WO PCT/EP2018/064282 patent/WO2018220068A1/en not_active Ceased
- 2018-05-30 CA CA3065417A patent/CA3065417A1/en active Pending
- 2018-05-30 DK DK18733182.2T patent/DK3630093T3/da active
- 2018-05-30 PL PL18733182.2T patent/PL3630093T3/pl unknown
- 2018-05-30 ES ES18733182T patent/ES3053709T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3065417A1 (en) | 2018-12-06 |
| ES3053709T3 (en) | 2026-01-26 |
| PL3630093T3 (pl) | 2025-12-08 |
| JP7395358B2 (ja) | 2023-12-11 |
| US20200179335A1 (en) | 2020-06-11 |
| EP3630093A1 (en) | 2020-04-08 |
| WO2018220068A1 (en) | 2018-12-06 |
| EP3630093B1 (en) | 2025-08-20 |
| JP2020521782A (ja) | 2020-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3728271T3 (da) | Makrocykliske forbindelser til behandling af sygdomme | |
| HUE064141T2 (hu) | Azolopirimidin rákkal összefüggõ rendellenességek kezelésére | |
| DK3347030T3 (da) | Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme | |
| PL3600309T3 (pl) | Skojarzenia terapeutyczne do leczenia chorób wątroby | |
| DK3169328T3 (da) | Quinolinderivater til behandling af inflammationssygdomme | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| DK3390390T3 (da) | Bipyrazolylderivater egnede til behandling af autoimmunsygdomme | |
| DK3777855T3 (da) | Fremgangsmåder til behandling af fibrotiske sygdomme | |
| DK3212233T3 (da) | Kombinationsterapi til behandling af sygdom | |
| DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
| DK3865484T3 (da) | Pde9-hæmmer med imidazopyrazinon-rygrad til behandling af perifere sygdomme | |
| DK3548061T3 (da) | Behandling af neurologiske sygdomme | |
| DK3097085T3 (da) | Benzoxazinonderivater til behandling af hudsygdomme | |
| DK3612208T3 (da) | Coversin til behandlingen af autoimmune sygdomme med blisterdannelse | |
| EP3735463A4 (en) | Cytotoxicity-inducing therapeutic agent | |
| DK3419622T3 (da) | Behandling af neurodegenerativ øjensygdom med pridopidin | |
| DK3192524T3 (da) | Hgf præparat egnet til behandling af neurologiske lidelser | |
| DK3576738T3 (da) | Gaboxadolmonohydrat i behandling af tinnitus | |
| DK3408265T3 (da) | Terapeutiske forbindelser | |
| DK3578562T3 (da) | L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme | |
| IL259486A (en) | Agents for the treatment of diseases associated with undesired cell proliferation | |
| IL262851A (en) | Combination prime: boost therapy | |
| DK3439661T3 (da) | Fremgangsmåder til behandling af øjenlidelser | |
| DK3297619T3 (da) | Terapeutiske anvendelser af L-4-chlorkynurenin | |
| EP3493821A4 (en) | METHOD OF TREATING THE RESPIRATORY TRACT |